Cohen Fred E — SEC insider filings

SEC reporting owner CIK 1339358. 35 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2020-09-22 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intellia Therapeutics, Inc. (NTLA)Director81 leg · 150,000 sh · $1,402,500—14
CareDx, Inc. (CDNA)Director12——20
Progyny, Inc. (PGNY)Director6——13
Kyverna Therapeutics, Inc. (KYTX)Director3——8
UroGen Pharma Ltd. (URGN)Director5——5
VERACYTE, INC. (VCYT)Director1——2

Insider filings — Cohen Fred E

FiledFormIssuerReported transactionsSource
2026-11-044CareDx, Inc. (CDNA)Gift (G): 25,000 @ $0EDGAR
2026-06-164CareDx, Inc. (CDNA)Grant/award (A): 9,795 @ $0EDGAR
2026-06-104Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 9,200 @ $0 · Grant/award (A): 13,300 (derivative) @ $0EDGAR
2026-05-294Kyverna Therapeutics, Inc. (KYTX)Grant/award (A): 5,093 @ $0 · Grant/award (A): 20,582 (derivative) @ $0EDGAR
2026-01-074Intellia Therapeutics, Inc. (NTLA)Purchase (P): 150,000 @ $9.35EDGAR
2025-06-174CareDx, Inc. (CDNA)Grant/award (A): 12,103 @ $0EDGAR
2025-06-134Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 8,000 @ $0 · Grant/award (A): 11,450 (derivative) @ $0EDGAR
2025-06-024Kyverna Therapeutics, Inc. (KYTX)Grant/award (A): 16,634 @ $0 · Grant/award (A): 65,351 (derivative) @ $0EDGAR
2024-08-084UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-06-204/ACareDx, Inc. (CDNA)Grant/award (A): 16,048 (derivative) @ $0EDGAR
2024-06-184CareDx, Inc. (CDNA)Grant/award (A): 10,570 @ $0 · Grant/award (A): 16,048 (derivative) @ $0EDGAR
2024-06-144Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 7,737 @ $0 · Grant/award (A): 11,515 (derivative) @ $0EDGAR
2024-05-284Progyny, Inc. (PGNY)Grant/award (A): 6,176 @ $0 · Grant/award (A): 25,070 (derivative) @ $0EDGAR
2024-02-144Kyverna Therapeutics, Inc. (KYTX)Conversion (C): 4,523,924 · Conversion (C): 4,401,771 (derivative) @ $0 · Conversion (C): 8,830,901 (derivative) @ $0 · Conversion (C): 7,356,162 (derivative) @ $0EDGAR
2023-09-084UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-07-284UroGen Pharma Ltd. (URGN)Grant/award (A): 69,339 @ $9.54EDGAR
2023-06-214CareDx, Inc. (CDNA)Grant/award (A): 18,844 @ $0 · Grant/award (A): 29,136 (derivative) @ $0EDGAR
2023-06-164Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 4,425 @ $0 · Grant/award (A): 6,473 (derivative) @ $0EDGAR
2023-05-264Progyny, Inc. (PGNY)Grant/award (A): 4,385 @ $0 · Grant/award (A): 18,350 (derivative) @ $0EDGAR
2023-01-094CareDx, Inc. (CDNA)Grant/award (A): 1,062 @ $0EDGAR
2022-10-264Progyny, Inc. (PGNY)Grant/award (A): 3,480 @ $0 · Grant/award (A): 15,660 (derivative) @ $0 · Grant/award (A): 1,460 (derivative) @ $0EDGAR
2022-10-044CareDx, Inc. (CDNA)Grant/award (A): 803 @ $0EDGAR
2022-06-214CareDx, Inc. (CDNA)Grant/award (A): 4,863 @ $0 · Grant/award (A): 7,606 (derivative) @ $0EDGAR
2022-06-164Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 5,197 @ $0 · Grant/award (A): 7,688 (derivative) @ $0EDGAR
2022-06-104UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-10-264Progyny, Inc. (PGNY)Grant/award (A): 2,652 @ $0 · Grant/award (A): 15,831 (derivative) @ $0EDGAR
2021-06-254Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 2,094 @ $0 · Grant/award (A): 3,382 (derivative) @ $0EDGAR
2021-06-214CareDx, Inc. (CDNA)Grant/award (A): 1,127 @ $0 · Grant/award (A): 1,812 (derivative) @ $0EDGAR
2021-06-094UroGen Pharma Ltd. (URGN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-01-224Intellia Therapeutics, Inc. (NTLA)Option exercise (M): 20,000 @ $13.78 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2021-01-064CareDx, Inc. (CDNA)Option exercise (M): 15,000 @ $14.74 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2020-11-204/AProgyny, Inc. (PGNY)Grant/award (A): 1,845 (derivative) @ $0EDGAR
2020-10-274Progyny, Inc. (PGNY)Grant/award (A): 6,000 @ $0 · Grant/award (A): 27,000 (derivative) @ $0 · Grant/award (A): 894 (derivative) @ $27.95EDGAR
2020-10-204VERACYTE, INC. (VCYT)Option exercise (M): 10,000 @ $7.60 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-09-224CareDx, Inc. (CDNA)Option exercise (M): 6,679 @ $5.49 · Option exercise (M): 9,745 @ $4.95 · Option exercise (M): 6,679 (derivative) @ $0 · Option exercise (M): 9,745 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1339358 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs